Veracyte Inc
VCYT
Market Cap$1.58B
Close$
$-5.19
122% downside
Current Fair Value
122% downsideOvervalued by 122% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.58 Billion |
|---|---|
| Enterprise Value | $1.38 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.02 |
| Beta | 1.99 |
| Outstanding Shares | 76,448,070 |
| Avg 30 Day Volume | 688,162 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -21.2 |
|---|---|
| PEG | 27.54 |
| Price to Sales | 5.89 |
| Price to Book Ratio | 1.68 |
| Enterprise Value to Revenue | 3.68 |
| Enterprise Value to EBIT | -123.67 |
| Enterprise Value to Net Income | -21 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
ESG Score
No data
About Veracyte Inc
CEO: Bonnie Anderson